+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Signal transduction pathways. Molecular targets for lithium's actions



Signal transduction pathways. Molecular targets for lithium's actions



Archives of General Psychiatry 52(7): 531-543



Lithium remains the most widely used treatment for bipolar disorder, and this monovalent cation represents one of psychiatry's most important treatments. Despite its demonstrated efficacy in reducing both the frequency and severity of recurrent affective episodes and decades of clinical use, the molecular mechanisms underlying its therapeutic actions have not fully been elucidated. In this report, we review the exciting recent progress in the identification of key components of signal transduction pathways (in particular, guanine nucleotide-binding proteins (G proteins), adenylyl cyclases, and protein kinase C isozymes) as targets for lithium's actions and attempt to integrate these effects with the large body of data emphasizing alterations in various neurotransmitter (particularly monoaminergic) systems. Regulation of signal transduction within critical regions of the brain by lithium affects the function of multiple neurotransmitter systems and may thus explain lithium's efficacy in protecting susceptible individuals from spontaneous, stress-induced, and drug-induced cyclic affective episodes. Recent evidence has also demonstrated significant effects of lithium on the regulation of gene expression in the central nervous system, effects that may play a major role in the long-term stabilization of mood. The identification of these intracellular targets for lithium's actions offers the potential for the development of novel, improved therapeutic agents And, in conjunction with molecular genetic approaches, may facilitate our understanding of the biological factors predisposing individuals to manic-depressive illness.

(PDF emailed within 1 workday: $29.90)

Accession: 009414879

Download citation: RISBibTeXText

PMID: 7598629


Related references

Signal transduction pathways, part C. Cell signaling in health and disease. Cell signal world: signal transduction pathways as therapeutic targets. Proceedings of a meeting. January 25-28, 2006. Luxembourg. Annals of the New York Academy of Sciences 1095: 1-609, 2007

Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochemical Pharmacology 68(6): 1089-1100, 2004

A microarray analysis of gene expression pre- and post-lithium treatment in acute mania Molecular signal transduction pathways. European Neuropsychopharmacology 14(Supplement 1): S61-S62, March, 2004

Signal transduction pathways as targets for therapeutics. Science's Stke 2001(76): Pe1-Pe1, 2001

Signal transduction pathways: new targets in oncology. Pharmacy World & Science 15(6): 233-242, 1993

Signal transduction pathways A goldmine for therapeutic targets. Sebti, Said M. , Hamilton, Andrew D. Cancer Drug Discovery And Development. Farnesyltransferase Inhibitors In Cancer Therapy. 1-20, 2001

Signal transduction and apoptosis pathways as therapeutic targets. Progress in Molecular and Subcellular Biology 36: 307-323, 2004

Identification of therapeutic targets in BCR/ABL signal transduction pathways. Journal of Molecular Medicine (Berlin) 75(7): B221, 1997

Intracellular signal transduction pathways as targets for neurotoxicants. Toxicology 160(1-3): 19-26, March 7th, 2001

Signal transduction pathways: new targets for treating rheumatoid arthritis. Joint, Bone, Spine 71(6): 503-510, 2004

Signal transduction pathways Targets for green and black tea polyphenols. Mutation Research 483(Suppl 1): S16, 20 October, 2001

Nuclear onco-protein targets of signal transduction pathways. Pigment Cell Research. 7(2): 96-100, 1994

Signal transduction pathways in sarcoma as targets for therapeutic intervention. Current Opinion in Oncology 13(4): 249-255, 2001

Signal transduction pathways as novel therapy targets in lung cancer. Lung Cancer 45 Suppl 2: S177-S186, 2004

Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet. Oncology 1: 181-188, 2002